This paper compared the diagnostic sensitivity, specificity, and accuracy of magnetic resonance (MR)-, computed tomography (CT)- and ultrasound (US)-guided liver biopsies.
Diagnostic yield of MR-guided liver biopsies compared with CT- and US-guided liver biopsies.
Schmidt AJ, Kee ST, Sze DY, Daniel BL, Razavi MK, Semba CP, Dake MD
Purpose
Conclusion
MR-, CT-, and US-guided liver biopsies were comparable in sensitivity, specificity, accuracy and false negative rates.
Studies (1)
Purpose
This study compared the diagnostic sensitivity, specificity, and accuracy of MR-, CT- and US-guided liver biopsies. Sixty-four MR-guided biopsies were performed on 60 patients with lesions difficult to visualize by CT or US using an 18-gauge (G) stabilization needle and a 21-G aspiration needle. CT-guided biopsies (30 patients) and US-guided biopsies (18 patients) were performed using a 19-G stabilization needle and a 21-G aspiration or 20-G core biopsy needle. The biopsy processing and analysis methods used were not discussed. The mean sizes of the lesions biopsied under the three different guidance methods were comparable.
Summary of Findings
MR-, CT-, and US-guided liver biopsies had comparable sensitivity (75%, 77% and 79%, respectively), specificity (100%, all), and accuracy (80%, 80% and 83%, respectively). A comparable number of false negatives occurred in a comparable number of MR-, CT-, and US-guided biopsies (13/64, 6/30 and 3/18, P=0.96). A significantly lower mean number of passes were conducted for US-guided biopsies (4.4) than CT (6.8, P=0.01), but the mean number of passes were comparable for MR-guided (5.3) biopsies and US- or CT- guided biopsies.
Biospecimens
CellLiverTissueLiverPreservation Types
EthanolOther PreservativeDiagnoses
NeoplasticBenignNeoplasticCarcinomaNeoplasticLymphomaNeoplasticSarcomaPlatforms
MorphologyLight microscopyPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Method of cell acquisition CT-guided biopsyMR-guided biopsyUS-guided biopsy